Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090974
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2004-09-07
Brief Title:
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I Stage II or Stage IIIA Primary Breast Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
CDR0000380937
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eastern Cooperative Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NCIC Clinical Trials Group | NETWORK |
| National Cancer Institute NCI | NIH |